PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for January 22, 2009 Subscribe to this News Feed    
 

ExtendSnacks™ Not Affected by FDA Peanut Butter Recall

ExtendSnacks™, a leading brand of foods that help control blood sugar, announced that none of their products or ingredients are affected in any way by the recent peanut butter recall put into effect by the FDA. ExtendSnacks does not buy any ingredients from Peanut Corporation of America (PCA), the source of the current salmonella outbreak.

St. Louis, MO (PRWEB) January 22, 2009 -- ExtendSnacks™, a leading brand of foods that help control blood sugar, announced that none of their products or ingredients are affected in any way by the recent peanut butter recall put into effect by the FDA. ExtendSnacks does not buy any ingredients from Peanut Corporation of America (PCA), the source of the current salmonella outbreak.

While various nutritional products containing peanut butter or peanut paste are being recalled, ExtendSnacks™ are not linked to this outbreak. This includes all of their product forms - ExtendBar™ Delights, ExtendBar™ Crunches, ExtendCrisps™ and ExtendShakes™. The FDA is maintaining a list of affected brands on its website at the FDA Peanut Butter Recall Web Site - you will not find any ExtendSnacks brands on this list.

"ExtendSnacks™ is committed to providing our customers with safe, wholesome, and quality food products now and for the future," said company president Vijay Chauhan.

About ExtendSnacks™

ExtendSnacks™ are manufactured and marketed by Clinical Products, LLC, headquartered in St. Louis, MO. The original ExtendBar® was invented by Dr. Francine Kaufman, former president of the American Diabetes Association; current head of the Center for Diabetes, Endocrinology and Metabolism at Childrens Hospital Los Angeles; author of Diabesity; and a distinguished professor of pediatrics at the Keck School of Medicine. The continued mission of Clinical Products is to create great-tasting, convenient food products that help control blood sugar. ExtendSnacks™ are the only snacks clinically proven to help stabilize blood sugar for up to 9 hours, providing the benefits of hunger control and long-lasting energy. For more information visit http://www.ExtendBar.com or call 800-887-2919.

ExtendBar® is available at Walgreens stores nationwide, in Southern California at Albertson's in the Diet/Diabetic section and Ralph's in the Adult Nutrition section, in Arizona at Hi-health, in the Midwest at Hy-Vee and online at the ExtendSnacks Web Site or at 800-887-2919.

If you'd like more information about this topic, or to schedule an interview, please contact Jonathan Lindberg, (314) 336-0587 x327.

Childrens Hospital Los Angeles holds patents and/or patent applications on the underlying technology of ExtendBar®, which it has licensed to Clinical Products Ltd. Francine R. Kaufman, M.D., holds stock in, and is a consultant for, Clinical Products Ltd. Childrens Hospital Los Angeles and Dr. Kaufman benefit financially from the sales of ExtendBar®.

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1GYWx1LUluc2UtRW1wdC1GYWx1LVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Jonathan Lindberg
Clinical Products, LLC
314-336-0588
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move